EPOPLUS GMBH & CO KG has a total of 57 patent applications. Its first patent ever was published in 2003. It filed its patents most often in China, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NUTRATEC S R L, SUPRANATURALS LLC and SDC SWEDENCARE AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | Israel | 4 | |
#5 | Japan | 4 | |
#6 | United States | 4 | |
#7 | Canada | 3 | |
#8 | Croatia | 3 | |
#9 | Iceland | 3 | |
#10 | Republic of Korea | 3 | |
#11 | New Zealand | 3 | |
#12 | Ukraine | 3 | |
#13 | Brazil | 2 | |
#14 | Norway | 2 | |
#15 | Poland | 2 | |
#16 | Singapore | 2 | |
#17 | South Africa | 2 | |
#18 | EAPO (Eurasian Patent Organization) | 1 | |
#19 | Hong Kong | 1 | |
#20 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Haller Hermann | 41 |
#2 | Bahlmann Ferdinand Hermann | 39 |
#3 | Hermann Haller | 8 |
#4 | Ferdinand Hermann Bahlmann | 4 |
#5 | Hermann Bahlmann Ferdinand | 4 |
#6 | Bahlmann Ferdinand Hermann Dr | 2 |
#7 | Haller Hermann Prof Dr | 2 |
#8 | Hallerhermann | 1 |
#9 | Bahlmannferdinandhermann | 1 |
#10 | Hermann Bahlmann Ferdinand Her | 1 |
Publication | Filing date | Title |
---|---|---|
EP1711201A2 | Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages | |
NZ553426A | Use of erythropoietin for treating diabetes mellitus | |
CN101099860A | Use of erythropoietin |